These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35466937)

  • 41. The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS Study.
    Graham L; Ngwa J; Ntekim O; Ogunlana O; Johnson S; Nadarajah S; Fungwe TV; Turner J; Ruiz MR; Khan J; Obisesan TO
    J Racial Ethn Health Disparities; 2023 Aug; 10(4):1837-1845. PubMed ID: 35931916
    [TBL] [Abstract][Full Text] [Related]  

  • 42. African American participation in Alzheimer's disease research that includes brain donation.
    Darnell KR; McGuire C; Danner DD
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):469-76. PubMed ID: 22009227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baseline Results: The Association Between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study.
    Kumar VV; Huang H; Zhao L; Verble DD; Nutaitis A; Tharwani SD; Brown AL; Zetterberg H; Hu W; Shin R; Kehoe PG; Quyyumi A; Nocera J; Kippels A; Wharton W
    J Alzheimers Dis; 2020; 75(1):109-117. PubMed ID: 32280088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's disease.
    Akinleye I; Roberts JS; Royal CD; Linnenbringer E; Obisesan TO; Fasaye GA; Green RC
    J Genet Couns; 2011 Dec; 20(6):650-9. PubMed ID: 21656311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
    BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
    Zhang P; Hou Y; Tu W; Campbell N; Pieper AA; Leverenz JB; Gao S; Cummings J; Cheng F
    Alzheimers Dement; 2023 May; 19(5):1876-1887. PubMed ID: 36331056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma Biomarkers of Alzheimer's Disease in African Americans.
    Deniz K; Ho CCG; Malphrus KG; Reddy JS; Nguyen T; Carnwath TP; Crook JE; Lucas JA; Graff-Radford NR; Carrasquillo MM; Ertekin-Taner N
    J Alzheimers Dis; 2021; 79(1):323-334. PubMed ID: 33252078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.
    Weissberger GH; Strong JV; Stefanidis KB; Summers MJ; Bondi MW; Stricker NH
    Neuropsychol Rev; 2017 Dec; 27(4):354-388. PubMed ID: 28940127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retaining Participants in Longitudinal Studies of Alzheimer's Disease.
    Gabel M; Bollinger RM; Coble DW; Grill JD; Edwards DF; Lingler JH; Chin E; Stark SL
    J Alzheimers Dis; 2022; 87(2):945-955. PubMed ID: 35404282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
    Hampel H; Lista S; Khachaturian ZS
    Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment of Older African Americans in Alzheimer's Disease Clinical Trials Using a Community Education Approach.
    Shaw AR; Perales-Puchalt J; Moore T; Weatherspoon P; Robinson M; Hill CV; Vidoni ED
    J Prev Alzheimers Dis; 2022; 9(4):672-678. PubMed ID: 36281671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remote data collection speech analysis and prediction of the identification of Alzheimer's disease biomarkers in people at risk for Alzheimer's disease dementia: the Speech on the Phone Assessment (SPeAk) prospective observational study protocol.
    Gregory S; Linz N; König A; Langel K; Pullen H; Luz S; Harrison J; Ritchie CW
    BMJ Open; 2022 Mar; 12(3):e052250. PubMed ID: 35292490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding Online Registry Facilitators and Barriers Experienced by Black Brain Health Registry Participants: The Community Engaged Digital Alzheimer's Research (CEDAR) Study.
    Ashford MT; Zhu D; Bride J; McLean E; Aaronson A; Conti C; Cypress C; Griffin P; Ross R; Duncan T; Deng X; Ulbricht A; Fockler J; Camacho MR; Flenniken D; Truran D; Mackin SR; Hill C; Weiner MW; Byrd D; Turner Ii RW; Cham H; Rivera Mindt M; Nosheny RL
    J Prev Alzheimers Dis; 2023; 10(3):551-561. PubMed ID: 37357297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Cognitive Turning Point in Development of Clinical Alzheimer's Disease Dementia and Mild Cognitive Impairment: A Biracial Population Study.
    Rajan KB; Wilson RS; Barnes LL; Aggarwal NT; Weuve J; Evans DA
    J Gerontol A Biol Sci Med Sci; 2017 Mar; 72(3):424-430. PubMed ID: 28043942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults.
    Eliacin J; Polsinelli AJ; Epperson F; Gao S; Van Heiden S; Westmoreland G; Richards R; Richards M; Campbell C; Hendrie H; Risacher SL; Saykin AJ; Wang S
    Alzheimers Dement (N Y); 2023; 9(2):e12399. PubMed ID: 37287470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racially diverse participant registries to facilitate the recruitment of African Americans into presymptomatic Alzheimer's disease studies.
    Cocroft S; Welsh-Bohmer KA; Plassman BL; Chanti-Ketterl M; Edmonds H; Gwyther L; McCart M; MacDonald H; Potter G; Burke JR
    Alzheimers Dement; 2020 Aug; 16(8):1107-1114. PubMed ID: 32543781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild cognitive impairment.
    Giannisis A; Al-Grety A; Carlsson H; Howell JC; Hu WT; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2023 Jul; 15(1):119. PubMed ID: 37400888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.